Outset Medical
About: Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.
Employees: 354
0
Funds holding %
of 7,323 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
599% more capital invested
Capital invested by funds: $23.4M [Q4 2024] → $163M (+$140M) [Q1 2025]
43.16% more ownership
Funds ownership: 40.07% [Q4 2024] → 83.23% (+43.16%) [Q1 2025]
12% less call options, than puts
Call options by funds: $2.35M | Put options by funds: $2.67M
19% less funds holding
Funds holding: 74 [Q4 2024] → 60 (-14) [Q1 2025]
45% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 31
98% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 42
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
Low target
$21
24%
upside
Avg. target
$21
24%
upside
High target
$21
24%
upside
1 analyst rating
0 positive
0%
1 neutral
100%
0 negative
0%
RBC Capital Shagun Singh | 24%upside $21 | Sector Perform Maintained | 21 May 2025 |
Financial journalist opinion
Based on 3 articles about OM published over the past 30 days
Neutral
GlobeNewsWire
6 hours ago
Outset Medical Names First Chief Nursing Officer
SAN JOSE, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced Brittni McGill has been named to the newly created role of Chief Nursing Officer where she will apply her extensive nurse executive leadership experience to help increase strategic outreach and clinical program innovation designed to empower nurses and nurse leaders and elevate care.
Neutral
GlobeNewsWire
1 week ago
Outset Medical to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025
SAN JOSE, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the second quarter 2025 after the close of trading on Wednesday, August 6, 2025.
Positive
Seeking Alpha
3 weeks ago
Why Outset Medical's Rock-Bottom Valuation Masks Explosive Growth
The company's business model leverages recurring revenue streams and strong customer retention, supporting stable long-term growth. Key risks include potential regulatory changes and execution challenges that could impact future earnings. With FDA hurdles behind it and sales momentum building, Outset's Tablo is regaining traction across hospitals and ICU settings.
Positive
Zacks Investment Research
1 month ago
Strength Seen in Outset Medical (OM): Can Its 15.0% Jump Turn into More Strength?
Outset Medical (OM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Neutral
GlobeNewsWire
1 month ago
Outset Medical to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
SAN JOSE, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that management will present at the Goldman Sachs 46th annual Healthcare conference on Wednesday, June 11, 2025, at 11:20 a.m. Eastern time.
Neutral
GlobeNewsWire
1 month ago
Outset Medical Appoints Renee Gaeta as Chief Financial Officer
SAN JOSE, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced the appointment of Renee Gaeta as Chief Financial Officer (CFO), effective immediately. In addition to leading Finance, Ms. Gaeta will have responsibility for Outset's Information Technology and Human Resources organizations. She succeeds Nabeel Ahmed who is leaving the company to pursue other opportunities.
Neutral
GlobeNewsWire
2 months ago
Outset Medical Appoints Industry Veteran Kevin O'Boyle to its Board of Directors
SAN JOSE, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced the appointment of healthcare industry veteran Kevin O'Boyle to its Board of Directors and as chair of its Audit Committee. With Mr. O'Boyle's appointment, the company also announced that Dale E. Jones has stepped down from the Board.
Neutral
GlobeNewsWire
2 months ago
Outset Medical to Present at RBC Global Healthcare Conference
SAN JOSE, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate at the RBC Capital Markets Global Health Care conference on Tuesday, May 20, 2025, at 10:30 a.m. Eastern time.
Neutral
Seeking Alpha
2 months ago
Outset Medical, Inc. (OM) Q1 2025 Earnings Call Transcript
Outset Medical, Inc. (OM) Q1 2025 Earnings Call Transcript
Negative
Zacks Investment Research
2 months ago
Outset Medical, Inc. (OM) Reports Q1 Loss, Tops Revenue Estimates
Outset Medical, Inc. (OM) came out with a quarterly loss of $3.24 per share versus the Zacks Consensus Estimate of a loss of $0.97. This compares to loss of $8.55 per share a year ago.
Charts implemented using Lightweight Charts™